Skip to main content

Table 4 Costa of treatment by treatment group

From: Economic evaluation of AbobotulinumtoxinA vs OnabotulinumtoxinA in real-life clinical management of cervical dystonia

  AboBoNT-A LS Mean (95% CI) OnaBoNT-A LS Mean (95% CI) Differenceb (95% CI)
Unadjusted Model 310.31 (294.83, 325.78) 355.87 (331.61, 380.13) −45.57 (−74.35, − 16.79)
Adjusted Modelc 314.07 (299.1, 329.03) 346.63 (322.85, 370.42) −32.57 (− 61.04, − 4.09)
  1. aCost was calculated based on retail drug cost in euros
  2. bDifference was calculated as: mean of aboBoNT-A minus mean of onaBoNT-A
  3. cModel adjusted for sex, prior treatment with botulinum neurotoxin type A and electromyography (EMG) at baseline
  4. aboBoNT-A abobotulinumtoxinA; onaBoNT-A onabotulinumtoxinA; LS Least-Square; CI Confidence Interval